Zobrazeno 1 - 10
of 47
pro vyhledávání: '"T A, Bektimirov"'
Publikováno v:
Voprosy virusologii. 53(2)
The diagnostic value of enzyme immunoassay systems manufactured by different companies was comparatively studied to detect specific IgM antibodies to measles virus. The assay systems were shown to have a high sensitivity. The specificity was higher i
Autor:
T A, Bektimirov
Publikováno v:
Voprosy virusologii. 47(3)
The results of clinical trials of three types of candidate anti-AIDS vaccines are presented. Immunogenicity of different vaccine types and modern requirements to vaccines are analyzed. The advantages and disadvantages of protein, vector, and DNA vacc
Autor:
I V, Fel'dblium, N N, Vorob'eva, A M, Nikolaeva, V N, Borisova, V A, Mel'nikov, M V, Budanov, I A, Iakovleva, A V, Kaz'ianin, E V, Pushkareva, V N, Griaznov, D V, Griaznova, N V, Shalunova, O V, Perelygina, N A, Ozeretskovskiĭ, T A, Bektimirov
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (6)
Bubo-M, the first Russian combined vaccine, was found to have low reactogenicity. The difference between the number of postvaccinal reactions in the group of children immunized with Bubo-M (25.9%) and those in the group of children who had been simul
Autor:
I V, Fel'dblium, N N, Vorob'eva, A M, Nikolaeva, V N, Borisova, V A, Mel'nikov, M V, Budanov, I A, Iakovleva, A V, Kaz'ianin, E V, Pushkareva, D V, Griaznova, N V, Shalunova, O V, Perelygina, N A, Ozeretskovskiĭ, T A, Bektimirov, N V, Isaeva
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (5)
Bubo-M, the first Russian associated vaccine, was found to have low reactogenicity and high immunogenic potency. The frequency of postvaccinal reactions in the group of persons immunized with Bubo-M (20%) appeared to be considerably lower than among
Publikováno v:
Voprosy virusologii. 47(1)
HV monoclonal antibodies (MAb) were produced in order to improve the quality of HBsAg detection and their specific characteristics were compared with those of other MAbs. MAbs were characterized by asymmetric interactions with the antigen when used a
Autor:
O A, Maksimova, V F, Popov, T A, Bektimirov, L V, Grigor'eva, T N, Iunasova, O P, Kaplunova, O K, Sharova
Publikováno v:
Voprosy virusologii. 46(5)
Morphological and immunofluorescent study of changes in the central nervous system of monkeys with mumps was carried out in order to determine the criteria of neurovirulence of different mumps virus strains. Quantitative evaluation showed a lower res
Autor:
A V, Noskova, M A, Gorbunov, L I, Pavlova, G A, El'shina, I S, Sharipova, L G, Karpovich, T I, Kalashnikova, T A, Bektimirov, V V, Rikhmer, V S, El'nikov
Publikováno v:
Voprosy virusologii. 45(6)
This paper sums up the results of controlled field clinical trials of adult and childhood variants of Harvix, inactivated vaccine from hepatitis A. The vaccine is weakly reactogenic and safe. After a single injection of Harvix-1440 vaccine to adults
Autor:
A N, Kanev, N V, Shalunova, S V, Netesov, O N, Iastrebova, E E, Musina, N G, Bocharova, V P, Mishin, N N, Kiselev, A V, Shystov, M A, Smerdova, T A, Bektimirov
Publikováno v:
Voprosy virusologii. 45(4)
A panel of anti-HCV sera (lot 03HC) was prepared from human sera obtained at blood transfusion centers and infectious hospitals. Donor sera and high-titer sera from patients infected with HCV were used. For positive samples, specific sera reactive wi
Autor:
M A, Gorbunov, A V, Noskova, G A, El'shina, T A, Bektimirov, L I, Pavlova, L A, Aksenov, A A, Ivanov
Publikováno v:
Voprosy virusologii. 45(1)
Controlled field clinical trials of Avaxim vaccine from hepatitis A (Pasteur-Merrier-Connot) were carried out in adults and children aged 3-14 years to evaluate its reactogenicity and antigenic properties. The vaccine was weakly reactogenic both in a
Autor:
V N, Ikoev, M A, Gorbunov, A G, Maĭdaniuk, L G, Karpovich, T V, Kalashnikova, T A, Bektimirov, E V, Karpova, Iu V, Nemtsov, M A, Muntlieva, N I, Kriuk
Publikováno v:
Voprosy virusologii. 44(3)
Russian cultural concentrated inactivated vaccine protecting from hepatitis A--Hep-A-in-vac was used for immunization of children. The vaccine is slightly reactogenic and completely safe in children aged 3-17 years vaccinated twice in a dose of 0.25